AVR 3.19% $15.15 anteris technologies ltd

Ann: Appendix 4C - quarterly, page-3

  1. 842 Posts.
    lightbulb Created with Sketch. 186
    Why wooo ashtool?

    RECENT HIGHLIGHTS

    • Record quarter for ADAPT sales which continue to accelerate.

    • Net cash outflows reduced by 23% over the previous quarter (excluding the R&D rebate).

    • Quarterly underlying sales1 are up 16% on the prior quarter.

    • Two separate patent applications for TAVR technologies were filed in the

      US.

    • A new funding facility was arranged for up to $10.0M in secured debt from Partners for Growth (after quarter close).

    • Entered into an exclusive supply agreement for TMVR with 4C Medical.

    • CardioCel® 3D moved from a pre-market programme to an expanded

      access programme.

    • The new Royal Adelaide Hospital (nRAH) officially opened on
      5 September 2017 – poised to positively impact infusion business sales.
    $3.7 million cash burn
    Last edited by Dazaau: 31/10/17
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$15.15
Change
-0.500(3.19%)
Mkt cap ! $291.2M
Open High Low Value Volume
$15.75 $15.75 $15.00 $294.3K 19.33K

Buyers (Bids)

No. Vol. Price($)
1 1135 $15.15
 

Sellers (Offers)

Price($) Vol. No.
$15.35 88 1
View Market Depth
Last trade - 16.10pm 29/07/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.